The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LiDCO To Report Fall In Revenue After Transition To HUP Business Model

Wed, 20th Feb 2019 11:57

LONDON (Alliance News) - LiDCO Group PLC on Wednesday said it expects to report a double-ditgit decline in revenue in its recently ended financial year as it transitions its clients to the newly launched HUP business model.

The hemodynamic monitoring company said it continues to make progress with its HUP offering. As of Tuesday, LiDCO said it had a total global contracted base of 191 HUP monitors, up from 96 reported at the end of January 2018. Revenue from annualised HUP contracts totalled GBP1.5 million, more than doubled from GBP730,000 a year prior.

Overall, LiDCO said its product revenue for the year to January 31 was GBP6.2 million, down from GBP6.9 million a year earlier, while total revenue, which includes third party products, was GBP7.3 million, also lower than GBP8.3 million in financial 2018.

In the US, the strong growth of HUP meant that recurring revenue, which includes per patient disposables and service contracts, grew nearly 50% compared with the prior year to GBP1.3 million from GBP850,000.

Meanwhile, in the UK, LiDCO was focused on a conversion of its largest customers to the HUP business model, which had a transitional impact on the company's sales revenue recognition within the financial year. As a result, sales in the final quarter were less than the usual peak and LiDCO product revenue for financial 2019 were GBP3.6 million, down from GBP4.1 million a year ago.

LiDCO revenue outside of the UK and US markets in financial 2019 were GBP1.3 million, down slightly from GBP1.4 million the year before. The company explained that strong revenue growth in Japan and preliminary orders from new distribution channels in Europe were offset by weaker demand from the Middle East region.

Looking ahead, the company said it continues to invest in geographical expansion, applying for several regulatory registrations in key target markets in South East Asia and Latin America.

The company intends to announce its results for the year on March 26.

"Whilst the transition to the HUP business model has a short-term effect of deferring sales, we are encouraged by the progress made having built a recurring revenue base of over GBP1.5 million in just 18 months from launch of the HUP business model," said Chief Executive Matt Sassone.

"With continued focus on LiDCO's HUP model, we are well-placed to grow the business in line with our objectives over the short to medium term," added Sassone.

LiDCO shares were trading 1.2% higher on Wednesday at 4.40 pence each.

More News
3 Apr 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 April RenewiTrading statementNext Fifteen Communications GroupFull Year 5 (at

Read more
14 Feb 2017 12:46

LiDCO posts extensive trading update

(ShareCast News) - Cardiovascular monitoring company LiDCO Group provided a trading update for the full year to 31 January on Tuesday, with product revenues in the period expected to be up 14% to £6.76m, with total revenues - including third party products - expected to be up by 8% to £8.21m. The AI

Read more
14 Feb 2017 09:11

LiDCO To Escape Red And Report Small Annual Pretax Profit

Read more
10 Jan 2017 11:50

LiDCO appoints Shane Doorish as head of North America

(ShareCast News) - Hemodynamic monitoring company LiDCO announced the appointment of Shane Doorish as head of North America on Tuesday, with immediate effect. The AIM-traded firm said Doorish was bringing with him 19 years of experience in the healthcare sector having originally trained as a critica

Read more
16 Dec 2016 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Dec 2016 08:07

LiDCO Raises GBP3 Million In Equity To Fund US Expansion Plans (ALLISS)

Read more
11 Oct 2016 11:37

LiDCO narrows loss in first half

(ShareCast News) - Hemodynamic monitoring company LiDCO announced its unaudited interim results for the six months to 31 July on Tuesday, with product revenues up 10% to £3.03m. The AIM-traded firm's total product revenues, including third party products, was up 5% to £3.77m, with US revenues up 37%

Read more
11 Oct 2016 08:27

LiDCO Stems Loss And Pumps Up Exports Of Blood Flow Monitors To US

Read more
11 Aug 2016 09:43

WINNERS & LOSERS SUMMARY: DFS Furniture Is Sitting Comfortably

Read more
25 May 2016 08:03

LiDCO Continues To Expect Year Of Sales Growth And Cash Generation

Read more
18 May 2016 15:05

AGM, EGM Calendar - Week Ahead

Read more
16 May 2016 14:18

Lidco inks US distribution deal with ICU Medical

(ShareCast News) - LiDCO has inked a distribution agreement with partner ICU Medical to sell the LiDCO IM non-invasive hemodynamic monitoring system in the US. LiDCO IM is a specially configured hemodynamic monitor produced exclusively for ICU Medical. It works solely in conjunction with LiDCO's non

Read more
16 May 2016 09:35

WINNERS & LOSERS SUMMARY: Markets Unimpressed By British Land Earnings

Read more
16 May 2016 07:28

LiDCO Signs US Distribution Deal With ICU Medical For IM System

Read more
21 Apr 2016 16:38

LiDCO shows off new hemodynamic monitoring tech

(ShareCast News) - Hemodynamic monitoring company LiDCO was busy in the US capital this week, showing off its new technology LiDCOunity monitor at the 2016 Annual Congress of Advanced Recovery and Perioperative Medicine. The conference is currently being held in Washington, D.C. LiDCO's board said

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.